Which one of the following drugs does not undergo the first-pass effect?
**Core Concept**
The first-pass effect refers to the rapid metabolism of a drug by the liver after oral administration, reducing its bioavailability. This phenomenon is significant for drugs with high hepatic extraction ratios.
**Why the Correct Answer is Right**
Since the correct answer is not provided, let's discuss the general principle. A drug that does not undergo the first-pass effect is usually administered via a route that bypasses the liver initially, such as intravenous, intramuscular, or sublingual, or it has a very low hepatic extraction ratio, allowing a significant portion of the drug to reach systemic circulation without initial liver metabolism.
**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific drug, we can't comment on its pharmacokinetics directly, but typically, drugs that undergo significant first-pass metabolism are those that are orally administered and have high lipid solubility or are substrates for hepatic enzymes like CYP3A4.
**Option B:** Similarly, without specifics, if a drug is known to have a high first-pass effect, it's because it's extensively metabolized by the liver upon first pass.
**Option C:** If a drug is known for bypassing first-pass metabolism, it's either due to its administration route or its low hepatic extraction ratio.
**Option D:** Again, specifics are needed, but drugs not undergoing first-pass effect are notable for their ability to reach systemic circulation without significant initial liver metabolism.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that the first-pass effect can significantly impact the oral bioavailability of drugs, and understanding this concept is crucial for predicting the efficacy and dosing of medications, especially those with narrow therapeutic indexes.
**Correct Answer:** Correct Answer: D. Nitroglycerin.